BioAge Labs, Inc. (BIOA)
(Delayed Data from NSDQ)
$4.12 USD
-0.28 (-6.36%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.11 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
BioAge Labs, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BIOA 4.12 -0.28(-6.36%)
Will BIOA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BIOA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BIOA
BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More
BIOA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BIOA
BioArtic: Latest data presented at AAIC 2025 reinforces lecanemab's clinical effect with ...
Lecanemab four-year efficacy and safety data to be presented at AAIC 2025 | BIOA Stock News
The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan ...
BIOA Crosses Above Average Analyst Target